GlucoSenz measures blood glucose level direct from the skin of your thumb – without the need to draw a blood sample

MIMOS in Healthcare

MIMOS is Malaysia’s national applied research and development centre that focuses on generating technology solutions that enable the government to provide better services.

In the field of healthcare and medical technologies, MIMOS develops need-based, consumer-centric solutions that have supported the consistent and quality delivery of medical and healthcare services.

 

Ongoing and successful projects include applications for the Ministry of Health; namely the Teleprimary Care – Oral Health Clinical Information System, the Malaysian Health Data Warehouse, Medical Treatment Information System, Patient Registry Information System, and Food Safety System of Malaysia.

Backed by strong capabilities in Artificial Intelligence, Data Analytics and Integration; along with other cutting-edge technologies such as photonics, smart sensors and Internet of Things, MIMOS is committed to driving continuous improvement in healthcare for Malaysia.

Features

  • Non-invasive – no needles are used as no blood sample is needed
  • Non- intrusive  – minimum human contact or intrusion of comfort
  • Non-destructive -samples are reusable for re-evaluation without causing damage or altering them
  • No need for reagent – all processes are purely in-situ

Technology Benefits

  • Painless, as no finger-pricking is involved
  • Minimal human contact minimises risks of infection
  • Hygienic, as no blood sample is needed
  • Ease of operation enables early diagnosis and promotes frequent use, which can lead to improved diabetes control

Future Plan

  • A three-year roadmap for GlucoSenz will include adding more parameters such as hemoglobin count and creatinine by 2021,
  • To miniaturise the device size to Spectro Nano (2021 to 2022) with possibility of blood parameters in the area of endocrine, and Spectro Pico (2022 to 2023) with multi-parameters

Value

Pre-diabetic and diabetic patients may need to monitor their blood glucose on a daily basis. For healthcare providers as well as for home users, GlucoSenz provides a monitoring method that is economical in the long run as it reduces or even eliminates the need for consumable medical supplies such as lancets, test strips and alcohol swabs. For the medical devices business, GlucoSenz can emerge as a new market segment.

Quality Over Quantity

Publication

1

10th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2017)

Pre-Clinical and Clinical Evaluation of Self-Developed non-invasive glucose screening device on human,
2

Journal of Innovative Optical Health Sciences, Volume 08, Issue 02, March 2015 ( J. Innov. Opt. Health Sci. 08, 1550013 (2015)

An assessment study of absorption effect: LED vs tungsten halogen lamp for noninvasive glucose detection,
3

2016 IEEE Conference

Regression Analysis on In-Vitro Rats Induced Blood Glucose Level Detection Towards Non-Invasive Diabetes
Monitoring on Human via Near Infrared Spectroscopy,
4

2012 IEEE-EMBS Conference on Biomedical Engineering and Sciences

Design of Fourier Transform Infrared Optical Sensor with manufacturing tolerance on interferometer arms
for application on non-invasive hypoglycemia and hyperglycemia detection,
5

2014 IEEE Conference on Systems, Process and Control (ICSPC 2014)

Glucose Level Determination using Diffuse Reflectance Near Infrared Spectroscopy and Chemometrics Analysis based on In Vitro Sample and Human Skin,
6

2014 IEEE Conference

Design and Analysis on Interferogram Performance based on Two Different Light Source Scheme Using Mach Zehnder Inteferometer for Blood Glucose Detection,

Intellectual Property

  1. PI 2016000841 / 20150001747 – Automated Chemometrics Process for Identifying Component in Liquid Sample
  2. PI 2015704087 / 20150001764 – Metallic repercuss apparatus and method for non-invasive biological subject
  3. 20150001801 – Blood Glucose Sensor Device
  4. Filing – Method and system of glucose spectral processing unit for accuracy improvement in glucose measurement (co-own with OSA Technology Sdn Bhd)